Daihan Pharmaceutical Co.,Ltd. (KOSDAQ:023910)
South Korea
· Delayed Price · Currency is KRW 29,000
+50 (0.17%)
Apr 29, 2026, 3:30 PM KST
Daihan Pharmaceutical Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 27,644 | 33,759 | 28,426 | 24,961 | 22,670 | Upgrade
|
| Depreciation & Amortization | 9,221 | 7,282 | 8,663 | 9,208 | 11,411 | Upgrade
|
| Loss (Gain) From Sale of Assets | -31.38 | -58.03 | -22.53 | 9.4 | -41.28 | Upgrade
|
| Loss (Gain) From Sale of Investments | -274.01 | -303.6 | -288.69 | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | 24.34 | 17.05 | 10.8 | -33.29 | -142.8 | Upgrade
|
| Other Operating Activities | 2,406 | 2,115 | 4,194 | 2,632 | 7,386 | Upgrade
|
| Change in Accounts Receivable | 199.83 | -385.22 | 437.93 | -2,172 | -10.94 | Upgrade
|
| Change in Inventory | -8,134 | -3,194 | 1,271 | -4,407 | 2,969 | Upgrade
|
| Change in Accounts Payable | 1.13 | 526.47 | -877.61 | 2,997 | -389.71 | Upgrade
|
| Change in Other Net Operating Assets | -5,452 | -4,115 | -2,954 | -4,194 | -3,234 | Upgrade
|
| Operating Cash Flow | 25,604 | 35,643 | 38,860 | 28,999 | 40,617 | Upgrade
|
| Operating Cash Flow Growth | -28.16% | -8.28% | 34.00% | -28.60% | 20.79% | Upgrade
|
| Capital Expenditures | -25,123 | -15,801 | -21,280 | -8,621 | -11,850 | Upgrade
|
| Sale of Property, Plant & Equipment | 31.4 | 58.04 | 22.53 | - | 41.66 | Upgrade
|
| Investment in Securities | -12,521 | -56,883 | 3,235 | 8,635 | 283.86 | Upgrade
|
| Other Investing Activities | 0 | 0 | 25 | 180 | 10 | Upgrade
|
| Investing Cash Flow | -37,612 | -72,626 | -17,998 | 193.48 | -11,515 | Upgrade
|
| Short-Term Debt Repaid | - | - | -2,500 | -200 | -1,000 | Upgrade
|
| Long-Term Debt Repaid | -37.12 | -38.79 | -4,080 | -16,817 | -4,300 | Upgrade
|
| Total Debt Repaid | -37.12 | -38.79 | -6,580 | -17,017 | -5,300 | Upgrade
|
| Net Debt Issued (Repaid) | -37.12 | -38.79 | -6,580 | -17,017 | -5,300 | Upgrade
|
| Repurchase of Common Stock | - | - | - | -3,418 | - | Upgrade
|
| Dividends Paid | -5,195 | -4,329 | -3,752 | -2,108 | -2,108 | Upgrade
|
| Financing Cash Flow | -5,232 | -4,368 | -10,332 | -22,543 | -7,408 | Upgrade
|
| Foreign Exchange Rate Adjustments | -89.82 | 1,152 | 113.04 | 441.94 | 671.96 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | 0 | -0 | Upgrade
|
| Net Cash Flow | -17,329 | -40,199 | 10,644 | 7,092 | 22,367 | Upgrade
|
| Free Cash Flow | 481.53 | 19,841 | 17,580 | 20,378 | 28,767 | Upgrade
|
| Free Cash Flow Growth | -97.57% | 12.86% | -13.73% | -29.16% | 1.77% | Upgrade
|
| Free Cash Flow Margin | 0.23% | 9.72% | 8.97% | 11.06% | 16.78% | Upgrade
|
| Free Cash Flow Per Share | - | 3374.38 | 2989.79 | 3405.01 | 4794.57 | Upgrade
|
| Cash Interest Paid | 2.69 | 1.81 | 52.47 | 582.23 | 451.55 | Upgrade
|
| Cash Income Tax Paid | 7,913 | 8,028 | 8,656 | 8,869 | 3,247 | Upgrade
|
| Levered Free Cash Flow | -4,364 | 12,013 | 13,570 | 17,249 | 25,715 | Upgrade
|
| Unlevered Free Cash Flow | -4,363 | 12,014 | 13,603 | 17,620 | 26,009 | Upgrade
|
| Change in Working Capital | -13,385 | -7,168 | -2,123 | -7,777 | -665.87 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.